Intensive glucose control and cardiovascular outcomes

The Lancet

Volumn 374, Issue 9689, 2009, Pages 522-

  Yudkin, John S ^a   Richter, Bernd ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE;

BLOOD PRESSURE; CARDIOVASCULAR RISK; GLUCOSE BLOOD LEVEL; ISCHEMIC HEART DISEASE; LETTER; PRIORITY JOURNAL; STROKE; CORONARY ARTERY DISEASE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERGLYCEMIA; HYPERTENSION; NOTE; RISK REDUCTION; TREATMENT OUTCOME;

CORONARY DISEASE; HUMANS; HYPERCHOLESTEROLEMIA; HYPERGLYCEMIA; HYPERTENSION; RISK REDUCTION BEHAVIOR; STROKE; TREATMENT OUTCOME;

EID: 68349127035     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(09)61478-1     Document Type: Letter

References (5)

1. Ray K.K., Seshasai S.R.K., Wijesuriya S., et al. Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials. Lancet 373 (2009) 1765-1772
2. Selvin E., Marinopoulos S., Berkenblit G., et al. Meta-analysis: glycosylated haemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med 141 (2004) 421-431
3. Law M.R., Morris J.K., and Wald N.J. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ 338 (2009) b1665
4. Prospective Studies Collaboration. Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55 000 vascular deaths. Lancet 370 (2007) 1829-1839
5. Cholesterol Treatment Trialists' Collaborators. Efficacy of cholesterol-lowering therapy in 18 686 people with diabetes in 14 randomised trials of statins: a meta-analysis. Lancet 371 (2008) 117-125